Olympus Co. (OTCMKTS:OLYMY – Get Free Report)’s share price was down 1.6% on Friday. The stock traded as low as $12.40 and last traded at $12.40. Approximately 21,337 shares were traded during mid-day trading, a decline of 76% from the average daily volume of 89,692 shares. The stock had previously closed at $12.60.
Wall Street Analyst Weigh In
Separately, The Goldman Sachs Group lowered Olympus from a “buy” rating to a “neutral” rating in a report on Monday, June 15th. One research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has an average rating of “Hold”.
Read Our Latest Analysis on Olympus
Olympus Trading Down 1.6%
About Olympus
Olympus Corporation is a Japan-based medical technology company that develops and manufactures equipment and systems used in minimally invasive procedures. Its primary business focuses on endoscopy and therapeutic solutions for hospitals, physicians and other health care providers.
The company’s products include gastrointestinal endoscopes and related imaging systems, surgical visualization equipment, electrosurgical devices and treatment instruments. Olympus also provides solutions used in urology, gynecology, respiratory care and ear, nose and throat procedures, along with service, training and other support for its medical technology portfolio.
Founded in 1919 as Takachiho Corporation, the company adopted the Olympus name in 1949 and historically operated businesses in cameras, audio products and scientific equipment.
See Also
- Five stocks we like better than Olympus
- Why Valley National Is Buying Growth Instead of Building It
- Carnival and CarMax Pop on Strong Earnings, but Challenges Remain
- 3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury Note
- 3 AI Winners, 3 Very Different Paths to Higher Margins
Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.
